文献速递系统性红斑狼疮

幼年起病系统性红斑狼疮大型队列中严重感染的相关因素:RELESSER注册研究

Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).
PubMed 文献 · Semin Arthritis Rheum · 2020-05-30

该研究基于西班牙风湿病学会狼疮注册库(RELESSER),回顾性分析353例幼年起病系统性红斑狼疮(jSLE)患者,严重感染(SI)发生率为3.7/100患者年(95%CI: 3.2-4.2),29.5%患者共发生205次SI。SI与更多SLE分类标准数、SLICC/ACR损伤指数评分及免疫抑制剂使用相关;首次感染时间缩短与更多SLE标准数、脾切除及免疫抑制剂使用相关。

要点

  • jSLE患者严重感染发生率为3.7/100患者年,风险显著高于成人SLE。
  • 更多SLE分类标准数、损伤累积及免疫抑制剂使用与严重感染相关。
  • 脾切除与首次感染时间缩短相关。

核心结论

  • jSLE患者严重感染风险显著,且高于成人SLE。
  • 严重感染与更多SLE分类标准数、损伤累积、某些免疫抑制剂使用及脾切除相关。

研究设计与样本

  • 基于西班牙风湿病学会狼疮注册库(RELESSER)的回顾性队列研究,纳入满足≥4项ACR-97 SLE标准且起病年龄<18岁的jSLE患者353例。
  • 严重感染定义为需住院并接受抗菌治疗的可能致命感染或感染导致的死亡,计算每100患者年的标化感染率。

主要发现

  • 353例患者中88.7%为女性,诊断年龄14.3岁(±2.9),病程16.0年(±9.3),随访结束时年龄31.5岁(±10.5)。
  • 104例(29.5%)患者共发生205次严重感染,其中发生1次者占55.8%,2-5次者占38.4%,≥6次者占5.8%。
  • 严重感染发生率为3.7/100患者年(95%CI: 3.2-4.2),呼吸道和细菌感染最常见。
  • 更多SLE分类标准数、SLICC/ACR DI评分及免疫抑制剂使用与严重感染存在相关。
  • 更多SLE分类标准数、脾切除及免疫抑制剂使用与首次感染时间缩短相关。

关键数值与推荐

  • 严重感染发生率3.7/100患者年(95%CI: 3.2-4.2)。
  • 104例(29.5%)患者发生205次严重感染,1次占55.8%、2-5次占38.4%、≥6次占5.8%。

临床怎么用

  • 对jSLE患者应警惕严重感染风险,尤其关注SLE分类标准数多、损伤累积、使用免疫抑制剂及脾切除者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the incidence of serious infection (SI) and associated factors in a large juvenile-onset systemic lupus erythematosus (jSLE) retrospective cohort. METHODS: All patients in the Spanish Rheumatology Society Lupus Registry (RELESSER) who meet ≥4 ACR-97 SLE criteria and disease onset <18 years old (jSLE), were retrospectively investigated for SI (defined as either the need for hospitalization with antibacterial therapy for a potentially fatal infection or death caused by the infection). Standardized SI rate was calculated per 100 patient years. Patients with and without SI were compared. Bivariate and multivariate logistic and Cox regression models were built to calculate associated factors to SI and relative risks. RESULTS: A total of 353 jSLE patients were included: 88.7% female, 14.3 years (± 2.9) of age at diagnosis, 16.0 years (± 9.3) of disease duration and 31.5 years (±10.5) at end of follow-up. A total of 104 (29.5%) patients suffered 205 SI (1, 55.8%; 2-5, 38.4%; and ≥6, 5.8%). Incidence rate was 3.7 (95%CI: 3.2-4.2) SI per 100 patient years. Respiratory location and bacterial infections were the most frequent. Higher number of SLE classification criteria, SLICC/ACR DI score and immunosuppressants use were associated to the presence of SI. Associated factors to shorter time to first infection were higher number of SLE criteria, splenectomy and immunosuppressants use. CONCLUSIONS: The risk of SI in jSLE patients is significant and higher than aSLE. It is associated to higher number of SLE criteria, damage accrual, some immunosuppressants and splenectomy.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Torrente-Segarra V, Salman-Monte TC, Rúa-Figueroa Í, et al. Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER). Semin Arthritis Rheum. 2020. PMID: 32505871. doi:10.1016/j.semarthrit.2020.05.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。